Amanda Skoll
Papers
1
Total Citations
76
H-Index
1
About
Amanda Skoll is a leading figure in pharmacogenomics, with a primary focus on the genetic variability of drug-metabolizing enzymes and its implications for personalized medicine. Her most-cited work, "Rapid Detection of CYP1A1, CYP2D6, and NAT Variants by Multiplex Polymerase Chain Reaction and Allele-Specific Oligonucleotide Assay" (1999), has garnered 76 citations, establishing a foundational methodology for the high-throughput genotyping of key cytochrome P450 and N-acetyltransferase genes. This contribution enabled more efficient screening for polymorphisms that affect drug efficacy and toxicity, directly advancing the clinical application of pharmacogenetic testing. Skoll’s research has been instrumental in bridging the gap between laboratory genetics and bedside practice, particularly in oncology and psychiatry, where variations in these enzymes can dramatically alter treatment outcomes. Her work remains a cornerstone for subsequent studies in drug metabolism and individualized therapy, underscoring her lasting impact on the field.
Research Focus
Key Achievements
Top Papers
- 1